Literature DB >> 27681652

Psychiatric comorbidities in children and adolescents with psoriasis: a population-based cohort study.

T Todberg1, A Egeberg1, P Jensen1, G Gislason2,3,4, L Skov1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27681652     DOI： 10.1111/bjd.15095

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  6 in total

1.  A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population.

Authors:  Amy S Paller; Jennifer Schenfeld; Neil A Accortt; Gregory Kricorian
Journal:  Pediatr Dermatol       Date:  2019-02-21       Impact factor: 1.588

2.  Cohort profile: the clinical 'Psoriasis in Adolescents' (PIA) cohort in Denmark.

Authors:  Christoffer Blegvad; Anne-Marie Nybo Andersen; Jonathan Groot; Claus Zachariae; Lone Skov
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

Review 3.  Off-Label Treatments for Pediatric Psoriasis: Lessons for the Clinic.

Authors:  Morten B Haulrig; Claus Zachariae; Lone Skov
Journal:  Psoriasis (Auckl)       Date:  2021-02-11

4.  Update on the Management of Pediatric Psoriasis: An Italian Consensus.

Authors:  Ketty Peris; Anna Belloni Fortina; Luca Bianchi; Gabriella Fabbrocini; Paolo Gisondi; Anna Balato; Federico Bardazzi; Nicoletta Bernardini; Domenico Bonamonte; Maria Rita Bongiorno; Cinzia Buligan; Francesco Cusano; Maria Beatrice De Felici Del Giudice; May El Hachem; Maria Concetta Fargnoli; Giulio Gualdi; Claudio Guarneri; Katharina Hansel; Giovanna Malara; Carlo Mazzatenta; Giuseppe Micali; Alessandra Narcisi; Iria Neri; Teresa Oranges; Michele Panzone; Aurora Parodi; Lucia Restano; Oriana Simonetti; Marina Venturini; Vito Di Lernia
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-01

5.  Association of Benzodiazepine Receptor Agonist Use With Changes in Psoriasis Severity in Adult Population: A Population-Based Study.

Authors:  Ke-Ting Pan; I-Hsun Li; Hui-Han Kao; Yi-Hsien Chen; Pei-Xun Zhong; Li-Ting Kao
Journal:  Front Pharmacol       Date:  2021-07-05       Impact factor: 5.810

6.  Adalimumab for severe psoriasis in Chilean paediatric patients.

Authors:  Daniela Armijo Fernandez; Fernando Valenzuela; Gustavo Saint-Pierre Contreras; Andrea Cortés González
Journal:  An Bras Dermatol       Date:  2019-12-30       Impact factor: 1.896
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.